Blastomycosis

8 registered clinical trials studyying Blastomycosis.

Status	Trial	Sponsor	Phase
Completed	A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica. NCT06523998	Caja Costarricense de Seguro Social	—
Completed	Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractor NCT03059992	Scynexis, Inc.	Phase 3
Terminated	Amphotericin-B and Voriconazole for Pulmonary Blastomycosis NCT02283905	University of Manitoba	Phase 4
Completed	A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and NCT00784368	Janssen Pharmaceutical K.K.	Phase 3
Completed	Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Der NCT00001702	National Cancer Institute (NCI)	—
Completed	Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis NCT00004808	National Center for Research Resources (NCRR)	Phase 2
Completed	Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis NCT00004811	National Center for Research Resources (NCRR)	Phase 1 / Phase 2
Completed	A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Am NCT00002159	Janssen, LP	Phase 3